DUBLIN–(BUSINESS WIRE)–The “Empty
Capsules Market by Product, Raw Material, Therapeutic Application and
End User – Global Opportunity Analysis and Industry Forecast, 2017-2025”
report has been added to ResearchAndMarkets.com’s
The global empty capsules market was valued at $1,841.5 million in 2017
and is projected to reach $3,707.5 million by 2025 growing at a CAGR of
9.1% from 2018 to 2025. Among raw materials, the pig meat segment
accounted for three-sevenths share of the total market in 2017.
Based on the product, the gelatin segment dominated the global market in
2017 and is expected to maintain this trend throughout the forecast
period. Whereas, the non-gelatin capsules segment are expected to grow
at the fastest pace from 2018 to 2025.
Based on therapeutic application, the antibiotic & antibacterial drugs
segment dominated the global market in 2017 and is anticipated to
continue this dominance throughout the forecast period. However, the
vitamin & dietary supplements segment is expected to grow at the fastest
pace throughout the forecast period.
The major companies profiled in this report include ACG Worldwide,
Bright Pharma Caps Inc., CapsCanada Corporation, Lonza Group Ltd.
(Capsugel), Medi-Caps Ltd., Mitsubishi Chemical Holdings Corporation
(Qualicaps, Inc.), Roxlor LLC, Snail Pharma Industry Co. Ltd, Suheung
Co., Ltd, and Sunil Healthcare Ltd.
The other prominent players in the value chain include Patheon Ltd.,
Nectar Lifesciences Ltd., JC Biological Technologies, Natural Capsules
Ltd., Zhejiang Huili Capsules Co., Ltd., Healthcaps India Limited, HTC
Group Limited, and Nanjing Saturn Pharmaceutical Technology Co., Ltd.
The CIS (Commonwealth of Independent States) region accounted for
one-ninth share of the global market in 2017.
The market for cardiac therapy drugs utilizing empty capsules are
expected to grow at the second-highest CAGR of 10.4% from 2018 to 2025.
North America dominated the global empty capsules market, accounting
for the maximum share in 2017 and is expected to retain a similar
trend during the forecast period.
Hydroxypropyl methylcellulose (HPMC) capsules raw material is growing
at the fastest pace during the forecast period.
The SGCs segment is estimated to grow at the highest CAGR of 8.1% from
2018 to 2025.
For more information about this report visit https://www.researchandmarkets.com/research/xhl4p6/the_global_empty?w=4
Laura Wood, Senior Manager
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900